Stock ALCAR CARMAT
Add to a list
To use this feature you must be a member
Log inSign up

CARMAT Stock

Equities

ALCAR

FR0010907956

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris
Other stock markets
 11:35:14 2024-05-31 am EDT 		5-day change 1st Jan Change
3.15 EUR -.--% Intraday chart for CARMAT +5.00% -52.99%
May. 21 CARMAT : Invest Securities remains Buy, lowers its target CF
May. 17 Oddo BHF Cuts Carmat PT, Affirms Neutral Rating MT

Financials

Sales 2024 * 14.85M 16.1M Sales 2025 * 37.48M 40.64M Capitalization 109M 118M
Net income 2024 * -39M -42.3M Net income 2025 * -30M -32.54M EV / Sales 2024 * 11 x
Net Debt 2024 * 54.4M 59M Net Debt 2025 * 100M 109M EV / Sales 2025 * 5.57 x
P/E ratio 2024 *
-2.36 x
P/E ratio 2025 *
-3.47 x
Employees 182
Yield 2024 *
-
Yield 2025 *
-
Free-Float 93.51%
More Fundamentals * Assessed data

Chart CARMAT

Dynamic Chart

Latest news about CARMAT

CARMAT : Invest Securities remains Buy, lowers its target CF
Oddo BHF Cuts Carmat PT, Affirms Neutral Rating MT
CARMAT : price target lowered by Oddo BHF CF
Carmat Raises EUR16 Million for Ongoing Operations, Clinical Trial MT
Carmat: 16 million euros successfully raised CF
Carmat: launches a fund-raising campaign of around €15 million CF
Carmat: progress in ongoing clinical study CF
CARMAT Continues to Build on Its Momentum in the EFICAS Study CI
Carmat SA Reiterates Sales Guidance for the Year 2024 CI
Carmat SA Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Carmat: final agreement with creditors CF
Carmat Secures Two-year Extensions for Bank Loans MT
CARMAT Announces a Final Agreement with All Its Financial Creditors on New Repayment Terms for Its Bank Loans CI
Carmat: up sharply, broker upgrades to 'buy CF
CARMAT : Invest Securities upgrades to 'buy'. CF
More news

Latest transcript on CARMAT

Logo CARMAT
Carmat SA - Special Call
More transcripts

Analyst Recommendations on CARMAT

CARMAT : Invest Securities remains Buy, lowers its target CF
Oddo BHF Cuts Carmat PT, Affirms Neutral Rating MT
CARMAT : price target lowered by Oddo BHF CF
Carmat: up sharply, broker upgrades to 'buy CF
CARMAT : Invest Securities upgrades to 'buy'. CF
More recommendations

Press releases CARMAT

CARMAT Announces the Approval of All Resolutions Supported by the Board of Directors at Its Annual General Meeting BU
CARMAT : Presentation on the occasion of the Combined General Meeting of 30 May 2024 PU
CARMAT Successfully Raises a Total of €16.0 Million BU
CARMAT : Inside Information / Other news releases PU
CARMAT Launches a Global Offering of Around €15 Million, With Subscription Commitments Totalling €8 Million BU
More press releases

News in other languages on CARMAT

Carmat: Degroof Petercam vise 9,5 euros
CARMAT annonce l’approbation de l’ensemble des résolutions soutenues par le Conseil d’administration lors de son assemblée générale
CARMAT : Présentation à l’occasion de l’Assemblée générale mixte du 30 mai 2024
CARMAT : Questions écrites posées au conseil d’administration de CARMAT SA – Assemblée générale mixte du 30 mai 2024
CARMAT : Document AMF CP. 2024DD967992
More news

Quotes and Performance

1 week+5.00%
1 month+4.65%
3 months-22.03%
6 months-13.58%
Current year-52.99%
More quotes

Highs and lows

1 week
2.99
Extreme 2.985
3.25
1 month
2.85
Extreme 2.85
4.40
Current year
2.85
Extreme 2.85
7.72
1 year
2.85
Extreme 2.85
9.99
3 years
2.85
Extreme 2.85
31.70
5 years
2.85
Extreme 2.85
36.00
10 years
2.85
Extreme 2.85
96.00
More quotes

Managers and Directors - CARMAT

Managers TitleAgeSince
Stéphane Piat CEO
 Chief Executive Officer 53 16-08-31
Pascale d’Arbonneau DFI
 Director of Finance/CFO - 18-12-11
Marc Grimmé CTO
 Chief Tech/Sci/R&D Officer - 08-06-24
Members of the board TitleAgeSince
Alexandre Conroy CHM
 Chairman 61 22-12-21
Pierre Bastid BRD
 Director/Board Member 69 18-04-04
Florent Battistella BRD
 Director/Board Member 61 21-05-06
More insiders

Quotes

Date Price Change Volume
24-05-31 3.15 -.--% 99,250
24-05-30 3.15 +2.94% 148,825
24-05-29 3.06 -0.33% 30,435
24-05-28 3.07 +1.32% 35,392
24-05-27 3.03 +1.00% 59,338

Real-time Euronext Paris, May 31, 2024 at 11:35 am EDT

More quotes

Company Profile

CARMAT specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnostics system. The artificial heart is intended for patients with advanced cardiac insufficiency who are ineligible for a transplant and have exhausted all medication alternatives.
Sector
Medical Equipment, Supplies & Distribution
Calendar
2024-06-06 - International Society for Mechanical Circulatory Support Conference
More about the company

Income Statement Evolution

More financial data

Ratings for CARMAT

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.15 EUR
Average target price
12.32 EUR
Spread / Average Target
+291.27%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Devices & Implants

1st Jan change Capi.
CARMAT Stock CARMAT
-52.99% 118M
STRYKER CORPORATION Stock Stryker Corporation
+13.73% 130B
SMITH & NEPHEW PLC Stock Smith & Nephew Plc
-8.17% 10.99B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Stock Imeik Technology Development Co.,Ltd.
-4.33% 8.35B
GLAUKOS CORPORATION Stock Glaukos Corporation
+41.80% 5.67B
INSPIRE MEDICAL SYSTEMS, INC. Stock Inspire Medical Systems, Inc.
-21.94% 4.72B
AXONICS, INC. Stock Axonics, Inc.
+7.81% 3.42B
ENOVIS CORPORATION Stock Enovis Corporation
-10.26% 2.76B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Balance Medical Technology Co.,Ltd.
-10.29% 2.11B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. Stock Shanghai MicroPort Endovascular MedTech Co., Ltd.
-13.58% 1.92B
Medical Devices & Implants
  1. Stock Market
  2. Equities
  3. ALCAR Stock